GW Pharma Wants Judge To Nix Investor Suit Over $7.2B Deal

By Sarah Jarvis (June 6, 2022, 7:57 PM EDT) -- GW Pharmaceuticals has asked a California federal judge to toss a proposed securities class action alleging the company misled investors to achieve a $7.2 billion acquisition deal, arguing that the purportedly misleading statements at issue were forward-looking and protected by cautionary language....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!